BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9071085)

  • 1. Leukocyte alkaline phosphatase activity and peripheral changes of granulocyte following administration of granulocyte colony-stimulating factor.
    Charuruks N; Krailadsiri P; Voravud N
    J Med Assoc Thai; 1996 Dec; 79(12):801-7. PubMed ID: 9071085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mobilization of autologous peripheral blood stem cells by combined chemotherapy and rhG-CSF].
    Shi H; Gu X; Zhu L
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):159-61. PubMed ID: 11783025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine kinase activity.
    Dotti G; Garattini E; Borleri G; Masuhara K; Spinelli O; Barbui T; Rambaldi A
    Br J Haematol; 1999 Apr; 105(1):163-72. PubMed ID: 10233380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
    Hazar V; Ongun H; Yeşilipek MA; Yeğin O
    Turk J Pediatr; 1999; 41(1):117-20. PubMed ID: 10770686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. rHuG-CSF increases the platelet-neutrophil complex formation and neutrophil adhesion molecule expression in volunteer granulocyte and stem cell apheresis donors.
    Karadogan C; Karadogan I; Bilgin AU; Undar L
    Ther Apher Dial; 2006 Apr; 10(2):180-6. PubMed ID: 16684221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the increasing serum lactate dehydrogenase caused by recombinant human granulocyte-colony stimulating factor].
    Sawa T; Yoshida T; Ikoma T; Toyoda M; Ohno Y; Fujiwara H
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):51-8. PubMed ID: 12557705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
    Scheding S; Media JE; Nakeff A
    Stem Cells; 1998; 16(2):144-51. PubMed ID: 9554039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy.
    Waller CF; von Lintig F; Daskalakis A; Musahl V; Lange W
    Bone Marrow Transplant; 1999 Jul; 24(1):19-24. PubMed ID: 10435729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor.
    Lee M; Aoki M; Kondo T; Kobayashi K; Okumura K; Komori K; Murohara T
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2535-41. PubMed ID: 16224058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on murine bone marrow and spleen erythropoiesis.
    Barrios L; Agustini MI; Poletti OH; Juaristi J; Brandan NC
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(1):18-24. PubMed ID: 9504189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High-dose chemotherapy supported by peripheral blood stem cells to treat intermediate--and high-grade non-Hodgkin's lymphomas].
    Ji Y; Ji S; Ju X
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):471-5. PubMed ID: 9387307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.
    Bernstein SH; Fay JP; Christiansen NP; Pinero L; Shah D; Stephan M; Herzig GP
    Clin Cancer Res; 1997 Sep; 3(9):1519-26. PubMed ID: 9815838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alkaline phosphatase activity in neutrophils from patients with severe congenital neutropenia (Kostmann's syndrome).
    Baranova K; Stanulla M; Zeidler C; Welte K
    Int J Hematol; 1999 Dec; 70(4):236-40. PubMed ID: 10643149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mobilization of autologous peripheral blood stem cells by chemotherapy and recombinant granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF)].
    Cui X; Shao Y; Ren B; Tong Z; Ren X; Li L; Zhang Z; Zhang N; Dai R; Hao X
    Zhonghua Xue Ye Xue Za Zhi; 2000 May; 21(5):247-9. PubMed ID: 11876989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.